Francisco Hermida-Prado

Principal Investigator

University of Oviedo
Country flagSpain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Year:

2025

Year:

2025

Year:

2025

The PIK3CA and SOX2 genes map at 3q26, a chromosomal region frequently amplified in head and neck cancers, which is associated with poor prognosis. This study explores the clinical significance of PIK3CA and SOX2 gene amplification in early tumorigenesis. Gene copy number was analyzed by real-time PCR in 62 laryngeal precancerous lesions and correlated with histopathological grading and laryngeal cancer risk. Amplification of the SOX2 and PIK3CA genes was frequently detected in 19 (31%) and 32 (52%) laryngeal dysplasias, respectively, and co-amplification in 18 (29%) cases. The PIK3CA and SOX2 amplifications were predominant in high-grade dysplasias and significantly associated with laryngeal cancer risk beyond histological criteria. Multivariable Cox analysis further revealed PIK3CA gene amplification as an independent predictor of laryngeal cancer development. Interestingly, combined PIK3CA and SOX2 amplification allowed us to distinguish three cancer risk subgroups, and PIK3CA and SOX2 co-amplification was found the strongest predictor by ROC analysis. Our data demonstrate the clinical relevance of PIK3CA and SOX2 amplification in early laryngeal tumorigenesis. Remarkably, PIK3CA amplification was found to be an independent cancer predictor. Furthermore, combined PIK3CA and SOX2 amplification is emerging as a valuable and easy-to-implement tool for cancer risk assessment in patients with laryngeal precancerous lesions beyond current WHO histological grading.

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Patricia García-Cabo

Central University Hospital of Asturias

SPAIN
View details

Kirsten Kübler

University Hospital Bonn

GERMANY
View details

Christian Sordo Bahamonde

University of Oviedo

SPAIN
View details

Juan Carlos De Vicente

University of Oviedo

SPAIN
View details

Alana Welm

Chair

Huntsman Cancer Institute

UNITED STATES
View details

Gema Moreno-Bueno

Head of Molecular Diagnostic Unit

Universidad Autónoma de Madrid

SPAIN
View details

Juana M. García-Pedrero

Principal Investigator

University of Oviedo

SPAIN
View details

Ramon Garcia-Escudero

Cientifico Titular

Centro de Investigaciones Energéticas Medioambientales y Tecnológicas

SPAIN
View details

Segundo Gonzalez

Catedrático

University of Oviedo

SPAIN
View details

Sheheryar Kabraji

Associate Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES
View details

Sean Fanning

Associate Professor with Tenure

Loyola University Chicago

UNITED STATES
View details

Iván Fernández-Vega

-

SPAIN
View details